You are currently on the new version of our website. Access the old version .
MDPIMDPI
Search all articles
VirusesViruses
Download PDF
  • Brief Report
  • Open Access

27 January 2026

Host Cell Receptor and Herpes Simplex Virus 1 Glycoprotein B Are Determinants of Low Temperature Entry

,
and
Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA
*
Author to whom correspondence should be addressed.
Viruses2026, 18(2), 163;https://doi.org/10.3390/v18020163
This article belongs to the Section Animal Viruses
Version Notes
Order Reprints

Abstract

Herpes simplex virus 1 (HSV-1) entry is a complex interplay of viral and host factors. The mechanisms of its regulation remain undefined. HSV-1 entry occurs via multiple distinct and cell-type dependent pathways, further complicating study of this process. HSV-1 strains with atypical entry properties aid in the elucidation of entry determinants. HSV-1 strain ANG path exhibits entry in Vero cells at 4 °C, whereas wild-type strains do not. We investigated the determinants of low temperature entry by HSV-1 ANG path in several cell types. The receptor nectin-2 mediated 4 °C entry of HSV-1 ANG path into CHO-K1 cells, but the related receptor nectin-1 did not, suggesting that gD-binding receptors are a determinant of HSV-1 entry at low temperatures. In HaCaT cells, both HSV-1 ANG path and wild-type strain KOS entered at 4 °C, while HSV-1 chimera 27/III, which contains KOS strain gB in the ANG path virus background, did not. This suggests that gB functions as a determinant of low temperature entry of HSV-1. Together, the findings suggest that there are multiple determinants and mechanisms of HSV-1 low temperature entry and that the requirements differ by cell type.

1. Introduction

Herpes simplex virus 1 (HSV-1), a widespread human pathogen, replicates in epithelial cells during both initial infection and following reactivation. Host cell fusion and entry are incompletely understood, yet essential to replication, transmission, and pathogenesis. HSV-1 entry is a complex, multi-step process that occurs via both endocytic and non-endocytic pathways [1,2,3,4]. The first step, attachment, is mediated by viral envelope glycoproteins B and C (gB and gC) interacting with cell surface heparan sulfate [5,6,7]. In a subset of cell types including human epidermal keratinocytes, HSV-1 is then endocytosed and ultimately fuses with an endosomal membrane [4,8]. In Vero cells or neurons, HSV-1 fuses directly with the plasma membrane [1,2,3,4,9,10,11,12,13,14]. A combination of viral and host cell factors determines HSV-1 fusion and selection of entry pathway [9,15,16,17,18,19,20].
HSV-1 entry mechanisms are typically studied at 37 °C in cell culture, in accordance with normal human core body temperature. However, entry at lower temperatures is of interest as these conditions can reduce cellular functions, such as endocytosis and protein function [21,22,23,24,25], and may have significance in the dynamic environment of surface exposed epithelia. Notably, low temperatures are restrictive for membrane fluidity and fusion [26,27,28,29] and thus should inhibit HSV-1 entry. We selected 4 °C to test as a temperature low enough to reliably inhibit endocytosis [21,22,23,24] and membrane fusion by other viruses [27,30]. Investigating how HSV-1 fusion occurs at 4 °C will aid in identifying determinants of fusion that are relevant to entry at 37 °C.
HSV-1 strain ANG path [31] is a laboratory-derived strain which exhibits several interesting entry and fusion phenotypes. ANG path is highly neuroinvasive, associated with 100% mortality in intraperitoneally infected mice [31] and mortality at markedly lower infectious doses via footpad inoculation compared to the ANG strain [32]. This increased pathogenicity is attributed to the A84G point mutation in ANG path glycoprotein D (gD) [32]. HSV-1 ANG path is syncytial and its glycoproteins are hyperfusogenic in a cell–cell fusion assay, phenotypes which are attributed to mutations in gB [18,33,34,35,36]. HSV-1 strain ANG, the parent of ANG path, enters Vero cells at 4 °C. The wild-type strain KOS does not enter under these conditions [33], despite entering by direct fusion with the plasma membrane [3]. This suggests that strain ANG can overcome some of the inhibitory effects of low temperatures on entry. We theorize that strain ANG path has a similar low temperature entry phenotype, enters other cell types at low temperatures, and could be a valuable tool for studying entry under these conditions.
HSV-1 ANG path enters cell types using receptors and entry pathways that are often different from the wild-type virus [15,18]. ANG path utilizes the nectin-2 receptor more efficiently than KOS, but is less efficient at utilizing the nectin-1 receptor favored by wild-type strains [15]. HSV also typically enters CHO cells, a model cell type commonly used for in vitro studies, via the pH-dependent endocytic pathway [8]. ANG path enters CHO-nectin-1 cells via this pathway, but in CHO-nectin-2 cells ANG path enters via direct fusion with the plasma membrane [15]. Thus, HSV-1 ANG path can be used to evaluate the effects of different entry receptors and pathways on low temperature entry.
HSV-1 enters human keratinocyte cell lines and mouse keratinocytes at temperatures as low as 7 °C [23,37]. HSV entry in epithelial cells is thought to predominantly occur via a non-conventional, low pH-dependent, endocytic pathway [4]; however, at low temperatures, this pathway should be unavailable for HSV entry due to the inhibition of cellular functions. Direct fusion of HSV-1 with the plasma membrane is exhibited during entry into neurons and other cell types. In these cases, cellular endocytosis of the virus is not required [3,4,11]. HSV-1 entry by direct penetration was detected in keratinocytes at low temperatures [23,37]. The cellular and viral factors that facilitate fusion at low temperatures is an important knowledge gap.
Based on the ability of HSV-1 ANG to enter at low temperatures, and of strain ANG path to utilize diverse receptors and entry pathways in common laboratory cell types, we hypothesize that HSV strain ANG path exhibits unique entry phenotypes in the human keratinocyte cell-derived cell line, HaCaT. In this study, we demonstrate that ANG path enters HaCaT cells efficiently at low temperatures despite entering via the pH-dependent endocytic pathway and that the hyperfusogenic gB of ANG path is essential to this phenotype. These findings support the use of HSV strain ANG path as a tool for further investigating atypical entry in physiologically relevant keratinocytes. Understanding the determinants of the unique entry and fusion activities of HSV-1 strain ANG will help decipher the HSV fusion reaction and entry process.

2. Materials and Methods

2.1. Cells and Viruses

CHO-K1 cells (American Type Culture Collection (ATCC), Manassas, VA, USA) were propagated in Ham’s F12 nutrient mixture (Gibco/Life Technologies, Grand Island, NY, USA), supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals, Atlanta, GA, USA) and 1X PSG. Vero cells (ATCC) and HaCaT cells were propagated in Dulbecco’s Modified Eagle’s Medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FBS and 1X PSG. CHO-nectin-2 (M2A) cells [38] were propagated in Ham’s F12 nutrient mixture, supplemented with 10% FBS, 1X PSG, 500 µg/mL G418 (Sigma-Aldrich, St. Louis, MO, USA), and 150 μg/mL puromycin (Sigma-Aldrich, St. Louis, MO, USA) to maintain stable transfection of the human nectin-2 receptor.
HSV-1 strain KOS was obtained from Priscilla Schaffer, Harvard University. HSV-1 strains ANG path [31] and chimeric strain KBang [36] were obtained from Thomas Holland, Wayne State University. HSV-1 chimeric strain 27/III [35] was obtained from Dietrich Falke, University of Mainz. HSV KBang is a chimeric strain with ANG path gB in a KOS background, and HSV-1 27/III is a chimeric strain with KOS gB in an ANG path background. All viruses were propagated and titer determined on Vero cells.

2.2. Antibodies

For plaque assays, cells were probed using rabbit anti-HSV polyclonal antibody HR50 (Biosynth International, Louisville, KY, USA) at a 1:400 dilution or goat anti-herpes simplex virus 1/2 polyclonal antibody (BioRad, Hercules, CA, USA) at a 1:250 dilution. Horseradish peroxidase recombinant Protein A (Invitrogen, Rockford, IL, USA) was used to detect primary antibody.

2.3. Plaque Assay

Herpes simplex virus 1 was titrated by limiting dilution. At 18–24 h p.i., culture medium was removed, and cells were fixed with ice-cold methanol-acetone solution (2:1 ratio) for 20 min at −20 °C and air-dried. Virus titer was determined by immunoperoxidase staining.

2.4. Nectin-1 Transfection

In a 10 cm dish, CHO-K1 cells were transfected with the pBG38 plasmid encoding human nectin-1 [39]. Transfections were performed using Attractene transfection reagent (Qiagen, Venlo, The Netherlands). Then, 24 h post-transfection, cells were trypsinized and re-seeded into twenty-four well-plates for use in plaque assays.

2.5. Low Temperature Entry Plaque Assay

Serial dilutions of HSV-1 (1:5) were prepared in carbonate-free, serum-free medium supplemented with 20 mM HEPES and 0.2% bovine serum albumin. Twenty-four well plate cell cultures and virus dilutions were equilibrated to 4 °C, 15 °C, or 37 °C for 15 min. Virus was added to cells (approximately 80 PFU/well), and cultures were incubated at 4 °C, 15 °C, or 37 °C for 2 h. Cells were treated with room temperature sodium citrate buffer (pH 3.0) at 37 °C for 5 min (Vero, CHO-nectin-2, CHO-nectin-1) or 3.5 min (HaCaT) to inactivate attached virus that had not entered the cells. At 18–24 h post-infection at 37 °C, virus titers were measured by plaque assay.

2.6. Effect of Ammonium Chloride on HSV-1 Entry

Stock solution of ammonium chloride (1.5 M) was prepared in water and subsequently diluted in complete DMEM. HaCaT cells grown in 24-well cell culture plates were treated with complete DMEM supplemented with ammonium chloride at twice the target concentration for 1 h at 37 °C. The NH4Cl concentrations used are non-cytotoxic to all cell types tested [8,40]. Virus was added at 100 PFU/well in the continued presence of the agent for 6 h. Medium was removed and replaced with complete DMEM. At 18 hpi, viral entry and infectivity was measured via plaque assay.

3. Results

3.1. Nectin-2 Mediates 4 °C Entry of HSV-1 ANG Path into CHO Cells

Previous results indicated that HSV-1 strain ANG enters Vero cells at 4 °C, in contrast to the wild type KOS virus which does not enter at 4 °C [33]. The HSV-1 ANG derivative, ANG path entered Vero cells at 4 °C (Figure 1A). There was a ~2 log decrease in ANG path entry at 4 °C relative to 37 °C. In contrast, there was no detectable entry of HSV-1 wild type KOS at 4 °C in Vero cells under these conditions.
Figure 1. Low temperature entry of HSV-1 ANG path on Vero and CHO cell types. Vero (A), CHO-nectin-1 (B), and CHO-nectin-2 cells (C) were infected with HSV-1 KOS (gray) or HSV-1 ANG path (red) for approximately 80 PFU/well at 37 °C, 15 °C, or 4 °C for 2 h. Cells were then washed with pH 3.0 sodium citrate buffer to inactivate surface-exposed virus, and incubated at 37 °C. At 18–24 hpi, infectivity was measured via plaque assay. Entry at 37 °C was set to 1.0. Results are the mean of triplicate samples from three independent experiments. Error bars represent standard deviation. *, p < 0.05, Welch’s t-test.
HSV-1 ANG path and KOS entered Vero cells at 37 °C and 15 °C. HSV-1 ANG and ANG path can utilize nectin-1 and nectin-2 receptors for entry [38,39]. To address the receptor requirements for low temperature entry, we investigated the ability of ANG path to enter CHO-nectin-1 (Figure 1B) or CHO-nectin-2 cells (Figure 1C). CHO cells are refractory to HSV entry, but expression of a gD-binding receptor renders CHO cells susceptible to HSV-1 entry [41]. HSV-1 ANG path entry at 4 °C was negligible on CHO-nectin-1 cells, suggesting that nectin-1 does not effectively facilitate 4 °C entry (Figure 1B). There was a ~4 log decrease in ANG path entry at 4 °C relative to 37 °C. In contrast, HSV-1 ANG path entered CHO-nectin-2 cells at 4 °C (Figure 1C), at a level similar to that observed in Vero cells (Figure 1A). There was a ~3 log decrease in ANG path entry at 4 °C relative to 37 °C. This indicates that the nectin-2 receptor is a determinant of HSV-1 entry at 4 °C.

3.2. HSV-1 ANG Path Enters Human Keratinocytes at 4 °C

Epithelial cells are the target of primary and recurrent HSV infections. We investigated low-temperature entry of HSV-1 ANG path on a more pathophysiologically relevant cell type, the human epidermal keratinocyte line, HaCaT. In HaCaT cells, wild type HSV-1 entry is facilitated by the nectin-1 receptor [39,42] and occurs via a low pH endocytic pathway [4]. HSV-1 ANG path also enters CHO-nectin-1 cells by a low pH endocytic pathway [15]. Therefore, we hypothesized that HSV-1 ANG path entry into HaCaT cells at 4 °C would be negligible, similar to the results we obtained in CHO-nectin-1 cells. Surprisingly, HSV-1 ANG path entered HaCaT cells at 4 °C, up to 1 log greater than HSV-1 wild type KOS (Figure 2). For both strains, entry was reduced at 4 °C relative to 37 °C; ~3 log for ANG path and ~4 log for KOS. Previous reports indicated that wild type HSV-1 enters keratinocytes at 7 °C [23,37]. Our results suggest that a low level of wild type HSV-1 entry into HaCaT cells persists at 4 °C.
Figure 2. Low temperature entry of HSV-1 on HaCaT cells. Cells were infected with HSV-1 KOS or HSV-1 ANG path for ~80 PFU/well at 37 °C, 15 °C, or 4 °C for 2 h. All cells were then washed with pH 3.0 sodium citrate buffer to inactivate surface exposed virus then incubated at 37 °C. Infectivity was measured via plaque assay at 18–24 hpi. Entry at 37 °C is set to 1.0. Results are the mean of triplicate samples from three independent experiments. Error bars represent standard deviation. ns, not significant, p > 0.05, Welch’s t-test.

3.3. HSV-1 ANG Path Enters HaCaT Cells by a Low pH Endocytic Pathway

We next determined the entry pathway that HSV-1 ANG path utilizes in HaCaT cells. HSV-1 ANG path entry into Vero cells and CHO-nectin-2 cells at 4 °C is robust relative to CHO-nectin-1 cells (Figure 1). This suggests that entry at 4 °C occurs via direct fusion with the plasma membrane. Direct fusion is thought to be a minor entry pathway for wild type HSV-1 in HaCaT cells at 7 °C [23]. Perhaps HSV-1 ANG path is better able to exploit the minor entry pathway of direct penetration in HaCaT cells. Ammonium chloride (NH4Cl), a weak base, inhibits HSV-1 entry via the low pH-dependent endocytic pathway by buffering the pH of cellular compartments [1]. We treated HaCaT cells with a range of concentrations of NH4Cl and assessed HSV-1 ANG path entry at 37 °C (Figure 3).
Figure 3. HSV-1 ANG path enters HaCaT cells via a low-pH-dependent pathway. HaCaT cells were treated with ammonium chloride for 1 h at 37 °C. HSV-1 KOS or ANG path was added (100 PFU/well) for 6 h in the continued presence of ammonium chloride. Drug-containing medium was replaced with culture medium. At 18 h post-infection, infectivity was determined by plaque assay. The infectivity of vehicle control (0 mM NH4Cl) samples was set to 100%. Results are the mean of quadruplicate samples from three independent experiments. Error bars represent standard deviation. *, p < 0.05; ns, p > 0.05, Welch’s t-test.
Ammonium chloride inhibited entry of both HSV-1 KOS and ANG path in a dose-dependent manner (Figure 3). This suggests that both strains are entering HaCaT cells via a low-pH-dependent pathway, consistent with pH-dependent endocytosis. The effect of ammonium chloride on entry into HaCaT cells at 4 °C was not able to be determined. The combination of ammonium chloride, citrate, and low temperature treatments was lethal to HaCaT cells. Altogether, the results suggest that 4 °C entry of HSV-1 can occur in cell types that support either pH-dependent endocytic (Figure 2 and Figure 3) or direct plasma membrane fusion pathways (Figure 1).

3.4. gB Is a Determinant of 4 °C Entry of HSV-1 ANG Path in HaCaT Cells

Many of the unique entry and fusion properties of HSV-1 ANG path are attributed to mutations in the core fusogen, gB. These phenotypes include syncytia formation, fusion from without (FFWO) [18,35,36], and hyperfusogenicity in a cell–cell fusion assay [33]. As such, we hypothesized that ANG path’s hyperfusogenic gB enables HSV-1 ANG path to overcome the energy restrictions of low temperature and contribute to 4 °C entry. We used chimeric HSV-1 strains 27/III and KBang to determine whether ANG path gB contributes to low-temperature entry in HaCaT cells (Figure 4).
Figure 4. ANG path gB is a determinant of HSV-1 entry into HaCaT cells at 4 °C. HaCaT cells were infected with HSV-1 strains 27/III or KBang (~80 PFU/well) at 37 °C, 15 °C, or 4 °C for 2 h. Cultures were treated with pH 3.0 sodium citrate to inactivate surface-exposed virus. At 18 hpi, infectivity was measured via plaque assay. Results are the means of triplicate samples from three independent experiments. Error bars represent standard deviation. ns, not significant, p > 0.05, Welch’s t-test.
HSV-1 27/III is a chimeric ANG path strain in which KOS gB replaces the native gB [35]. 27/III has ANG path gD and is expected to use nectin-2 as a receptor more efficiently than nectin-1. HSV-1 KBang has a KOS background with ANG path gB in place of the native gB [36]. KBang has KOS gD and is expected to use nectin-1 more efficiently than nectin-2, similar to the wild-type virus. HSV-1 KBang exhibited robust entry into HaCaT cells at 4 °C (Figure 4), similar to HSV-1 ANG path (Figure 2). There was a ~3 log decrease in KBang entry at 4 °C relative to 37 °C. In contrast, HSV-1 27/III entry into HaCaT cells was not detectable at 4 °C. This suggests that the hyperfusogenic ANG path gB is responsible for 4 °C entry into HaCaT cells. This contrasts with a previous finding that ruled out a role for ANG path gB in 4 °C entry [43].

4. Discussion

In this study, we demonstrate that nectin-2 and glycoprotein B are protein factors that allow HSV-1 to enter cells at 4 °C. The influence of either factor on 4 °C entry is cell type-dependent, suggesting multiple mechanisms at work (Figure 5). Host cell entry is an essential step in the herpesvirus replicative cycle and is a target for the development of preventative measures and treatments. Low-temperature entry is a rare phenotype for enveloped viruses and has only been described for HSV-1 [23,33,37,43] and Sindbis virus [44]. Low temperatures are inhibitory to HIV cell–cell fusion and influenza virus–cell fusion [30,45] and inactivate respiratory syncytial virus [46]. Studying the atypical phenotypes of HSV-1 ANG path, such as low-temperature entry, provides valuable insight into the mechanisms of HSV-1 fusion and entry.
Figure 5. Model of low temperature entry of HSV-1. gD-receptor interactions act as strong (soild-line arrow) or weak (dotted-line arrow) triggers for fusion. In HaCaT cells, additional factors interacting with gB (red receptor) may also activate gB and facilitate 4 °C entry. Receptors: Vero receptor (pink), nectin-1 (green), nectin-2 (blue).
The results here, together with previous studies, suggest that the proper gD-receptor interaction is one determining factor for 4 °C entry of HSV-1. ANG path gD was previously suggested to be a determinant of 4 °C entry [43]. Nectins are immunoglobulin-like adhesion molecules [47]. Nectin-1 binds to HSV-1 gD to initiate the membrane fusion cascade [48]. Nectin-2 is a receptor for HSV-1 ANG path, some clinical isolates of HSV-1 and HSV-2, and a weak receptor for laboratory strains of HSV-2 [38,49]. HSV-1 strains such as ANG path that carry mutations in gD, e.g., L25, Q27, or T230, permit entry and fusion mediated by nectin-2 [31,34,38,50,51,52]. Nectin-1 is a weak receptor for HSV-1 ANG path [15]. Nectin-2 but not nectin-1 mediates 4 °C entry of HSV-1 ANG path into CHO cells (Figure 1). However, nectin-1 was transiently expressed in CHO-K1 cells in this study, and receptor density was not quantitated, so it is possible that greater 4 °C entry of HSV would result from increased nectin-1 expression. Wild-type soluble gD inhibits entry of wild-type HSV-1 but not HSV-1 ANG path [43,53]. Interestingly, soluble ANG gD has an enhanced inhibitory effect on wild-type HSV-1 entry but fails to inhibit HSV-1 ANG path [43,53]. These results may be explained by differences in receptor affinity and this may also influence low temperature entry. Mutations in ANG path gD possibly affect receptor-triggered conformational change in gD, resulting in enhanced activation of gB fusion function (Figure 5).
ANG path gB is a determinant of 4 °C entry by HSV-1 ANG path in HaCaT cells (Figure 4). ANG path gB has a cytoplasmic tail mutation (A855V) and an ectodomain (V553A) mutation, which together are responsible for hyperfusogenic activity in glycoprotein-mediated cell–cell fusion and for fusion from without (FFWO) [35,36,54,55]. FFWO is virion-mediated cell–cell fusion without de novo viral protein synthesis and is another atypical property of HSV-1 ANG path [56]. FFWO shares key aspects with virus-cell fusion during entry such as dependence on an appropriate gD receptor for fusion. Similarly to 4 °C entry of HSV-1 ANG path, FFWO is only observed when the virus contains ANG path gB and the targets cells express an appropriate receptor [15,18]. In contrast, FFWO does not occur at low temperatures [56], suggesting it is not entirely analogous to 4 °C entry. Low pH-triggered conformational changes in gB mediate HSV-1 fusion during entry into human epithelial cells [57,58]. Interestingly, similar conformational changes occur in ANG path gB [59] and the antigenic conformation of ANG path gB is similar to that of low-pH-treated wild-type gB [18,57], supporting the notion that low pH triggers gB fusion activity and suggesting similarities in the functions of ANG path and KOS gB including similar responses to changes in pH.
We speculate that HSV-1 27/III does not enter HaCaT cells at 4 °C due to the weaker interaction of ANG path gD with the nectin-1 receptor and lack of a hyperfusogenic gB. Conversely, HSV-1 KBang with its nectin-1-binding gD and hyperfusogenic gB exhibits robust 4 °C entry in HaCaT cells (Figure 4). It is not known whether HaCaT cells express nectin-2; thus, the proportion of nectin-1 to nectin-2 in HaCaT cells is also not known. Altogether, low-temperature entry in HaCaT cells may require the contribution of multiple factors such as a specific gD-receptor interaction and hyperfusogenic ANG path gB function. HaCaT cells support 4 °C entry of ANG path, but CHO-nectin-1 cells do so to a lesser extent. Thus, we also propose that HSV-1 gB may function with an unidentified HaCaT cell co-factor to mediate low temperature entry (Figure 5). gB-binding receptors, such as paired immunoglobulin-like type 2 receptor and non-muscle myosin IIA, are potential candidates [16,60,61].
During HSV-1 entry, fusion can occur either directly at the cell plasma membrane (direct penetration) or with an endosomal membrane under the influence of low pH. Selection of entry pathway is determined by a complex combination of virus and cell factors [9,15,16,17,18,19,20,40]. Wild-type HSV-1 enters CHO-receptor cells by endocytosis. HSV-1 ANG path enters CHO-nectin-1 cells via endocytosis but CHO-nectin-2 cells by direct penetration [15]. Also, 4 °C entry of HSV-1 occurs in cell types that favor direct penetration (Vero [3] or CHO-nectin-2) [15] (Figure 1) or the endocytic pathway (HaCaT cells) [4] (Figure 2 and Figure 3). Host cell endocytosis and intracellular trafficking are delayed or inhibited at low temperatures [21,22,23,24] as is viral fusion with host membranes [62,63]. At 37 °C, HSV-1 KOS and ANG path enter HaCaT cells via low-pH-dependent endocytosis. Evidence suggests that HSV-1 entry at 7 °C proceeds primarily by an endocytic mechanism, with a minor role for direct penetration [23]. It remains possible that at 4 °C HSV-1 ANG path enters human keratinocytes via direct fusion at the plasma membrane and does so more efficiently than the wild-type virus. Further investigation is required to determine the precise entry pathway of HSV-1 in HaCaT cells at 4 °C.
Incorporation of the pH 3.0 citrate treatment at 2 hpi in this study allows for isolation and specific investigation of HSV-1 entry, separate from later steps in the replicative cycle. However, it cannot be ruled out that the effects of low temperature on cells persist, impeding HSV-1 replication. Further, these effects may differ across cell types. Low-temperature treatment of cells, including Vero cells, can induce microtubule depolymerization, although normal microtubule structure and distribution is recovered within 4–5 h after cells are returned to 37 °C [64,65]. Following HSV-1 entry into all cells, the nucleocapsid engages dynein/dynactin to travel on microtubules to the nuclear periphery. We do not expect microtubules to impact the fusion reaction at the plasma membrane. Thus, we do not anticipate our measurement of plasma membrane entry to be affected by microtubules. Similarly, in HaCaT cells, the actin cytoskeleton disassembles after incubation at 7 °C, but there is complete recovery after a subsequent 2 h incubation at 37 °C [23]. No change in microtubule morphology or tubulin concentration is detected after cold treatment of CHO-K1 cells [66]. In this study, following low-temperature incubation and citrate treatment, all cells are incubated at 37 °C for a minimum of 16 h, allowing for microtubule assembly. While steps downstream of HSV-1 entry may initially be delayed, we do not expect a significant effect on plaque formation measured at >16 h.
Overall, our findings support selective roles for both the gD–receptor interaction and gB in low-temperature entry of HSV-1. Further investigation of the unique entry and fusion phenotypes of HSV-1 ANG path and determinants of low temperature entry across cell types will contribute to our understanding of the complex determinants of HSV-1 entry.

Author Contributions

Conceptualization, C.M.L. and A.V.N.; methodology, M.A.H.; formal analysis, C.M.L.; investigation, C.M.L.; writing—original draft preparation, C.M.L.; writing—review and editing, M.A.H. and A.V.N.; supervision, A.V.N.; funding acquisition, A.V.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by grants R01GM152745, R21AI176338, and R03AI178458 from the National Institutes of Health.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
HSV-1Herpes simplex virus 1
FFWOFusion-from-without
gBGlycoprotein B
gDGlycoprotein D

References

  1. Nicola, A.V. Herpesvirus Entry into Host Cells Mediated by Endosomal Low pH. Traffic 2016, 17, 965–975. [Google Scholar] [CrossRef]
  2. Tebaldi, G.; Pritchard, S.M.; Nicola, A.V. Herpes Simplex Virus Entry by a Nonconventional Endocytic Pathway. J. Virol. 2020, 94, e01910-20. [Google Scholar] [CrossRef]
  3. Koyama, A.H.; Uchida, T. The mode of entry of herpes simplex virus type 1 into Vero cells. Microbiol. Immunol. 1987, 31, 123–130. [Google Scholar] [CrossRef]
  4. Nicola, A.V.; Hou, J.; Major, E.O.; Straus, S.E. Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J. Virol. 2005, 79, 7609–7616. [Google Scholar]
  5. Herold, B.C.; WuDunn, D.; Soltys, N.; Spear, P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 1991, 65, 1090–1098. [Google Scholar] [CrossRef]
  6. Shukla, D.; Spear, P.G. Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. J. Clin. Investig. 2001, 108, 503–510. [Google Scholar] [CrossRef]
  7. WuDunn, D.; Spear, P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 1989, 63, 52–58. [Google Scholar] [CrossRef] [PubMed]
  8. Nicola, A.V.; McEvoy, A.M.; Straus, S.E. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 2003, 77, 5324–5332. [Google Scholar] [CrossRef] [PubMed]
  9. Milne, R.S.; Nicola, A.V.; Whitbeck, J.C.; Eisenberg, R.J.; Cohen, G.H. Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. J. Virol. 2005, 79, 6655–6663. [Google Scholar] [CrossRef]
  10. Walker, E.B.; Pritchard, S.M.; Cunha, C.W.; Aguilar, H.C.; Nicola, A.V. Polyethylene glycol-mediated fusion of herpes simplex type 1 virions with the plasma membrane of cells that support endocytic entry. Virol. J. 2015, 12, 190. [Google Scholar] [CrossRef] [PubMed]
  11. Lycke, E.; Hamark, B.; Johansson, M.; Krotochwil, A.; Lycke, J.; Svennerholm, B. Herpes simplex virus infection of the human sensory neuron. An electron microscopy study. Arch. Virol. 1988, 101, 87–104. [Google Scholar] [CrossRef]
  12. Smith, G.A.; Pomeranz, L.; Gross, S.P.; Enquist, L.W. Local modulation of plus-end transport targets herpesvirus entry and egress in sensory axons. Proc. Natl. Acad. Sci. USA 2004, 101, 16034–16039. [Google Scholar] [CrossRef] [PubMed]
  13. Wittels, M.; Spear, P.G. Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway. Virus Res. 1991, 18, 271–290. [Google Scholar] [CrossRef]
  14. Curanovic, D.; Enquist, L. Directional transneuronal spread of α-herpesvirus infection. Future Virol. 2009, 4, 591. [Google Scholar] [CrossRef] [PubMed]
  15. Delboy, M.G.; Patterson, J.L.; Hollander, A.M.; Nicola, A.V. Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells. Virol. J. 2006, 3, 105. [Google Scholar] [CrossRef]
  16. Arii, J.; Uema, M.; Morimoto, T.; Sagara, H.; Akashi, H.; Ono, E.; Arase, H.; Kawaguchi, Y. Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha. J. Virol. 2009, 83, 4520–4527. [Google Scholar] [CrossRef] [PubMed]
  17. Gianni, T.; Campadelli-Fiume, G.; Menotti, L. Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes. J. Virol. 2004, 78, 12268–12276. [Google Scholar] [CrossRef]
  18. Roller, D.G.; Dollery, S.J.; Doyle, J.L.; Nicola, A.V. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity. Virology 2008, 382, 207–216. [Google Scholar] [CrossRef]
  19. Gianni, T.; Gatta, V.; Campadelli-Fiume, G. αVβ3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. Proc. Natl. Acad. Sci. USA 2010, 107, 22260–22265. [Google Scholar] [CrossRef]
  20. Stiles, K.M.; Milne, R.S.; Cohen, G.H.; Eisenberg, R.J.; Krummenacher, C. The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D. Virology 2008, 373, 98–111. [Google Scholar] [CrossRef]
  21. Tomoda, H.; Kishimoto, Y.; Lee, Y.C. Temperature effect on endocytosis and exocytosis by rabbit alveolar macrophages. J. Biol. Chem. 1989, 264, 15445–15450. [Google Scholar] [CrossRef]
  22. Larrick, J.W.; Enns, C.; Raubitschek, A.; Weintraub, H. Receptor-mediated endocytosis of human transferrin and its cell surface receptor. J. Cell Physiol. 1985, 124, 283–287. [Google Scholar] [CrossRef]
  23. De La Cruz, N.; Knebel-Mörsdorf, D. Endocytic Internalization of Herpes Simplex Virus 1 in Human Keratinocytes at Low Temperature. J. Virol. 2021, 95, e02195-20. [Google Scholar] [CrossRef]
  24. Lippincott-Schwartz, J.; Roberts, T.H.; Hirschberg, K. Secretory protein trafficking and organelle dynamics in living cells. Annu. Rev. Cell Dev. Biol. 2000, 16, 557–589. [Google Scholar] [CrossRef]
  25. Arcus, V.L.; Prentice, E.J.; Hobbs, J.K.; Mulholland, A.J.; Van der Kamp, M.W.; Pudney, C.R.; Parker, E.J.; Schipper, L.A. On the Temperature Dependence of Enzyme-Catalyzed Rates. Biochemistry 2016, 55, 1681–1688. [Google Scholar] [CrossRef] [PubMed]
  26. Quinn, P.J. Effects of temperature on cell membranes. Symp. Soc. Exp. Biol. 1988, 42, 237–258. [Google Scholar]
  27. Aroeti, B.; Henis, Y.I. Effects of fusion temperature on the lateral mobility of Sendai virus glycoproteins in erythrocyte membranes and on cell fusion indicate that glycoprotein mobilization is required for cell fusion. Biochemistry 1988, 27, 5654–5661. [Google Scholar] [CrossRef] [PubMed]
  28. Batzri, S.; Korn, E.D. Interaction of phospholipid vesicles with cells. Endocytosis and fusion as alternate mechanisms for the uptake of lipid-soluble and water-soluble molecules. J. Cell Biol. 1975, 66, 621–634. [Google Scholar] [CrossRef] [PubMed]
  29. Lee, D.C.; Chapman, D. The effects of temperature on biological membranes and their models. Symp. Soc. Exp. Biol. 1987, 41, 35–52. [Google Scholar]
  30. Chernomordik, L.V.; Frolov, V.A.; Leikina, E.; Bronk, P.; Zimmerberg, J. The pathway of membrane fusion catalyzed by influenza hemagglutinin: Restriction of lipids, hemifusion, and lipidic fusion pore formation. J. Cell Biol. 1998, 140, 1369–1382. [Google Scholar] [CrossRef]
  31. Kaerner, H.C.; Schröder, C.H.; Ott-Hartmann, A.; Kümel, G.; Kirchner, H. Genetic variability of herpes simplex virus: Development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain. J. Virol. 1983, 46, 83–93. [Google Scholar] [CrossRef] [PubMed]
  32. Izumi, K.M.; Stevens, J.G. Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J. Exp. Med. 1990, 172, 487–496. [Google Scholar] [CrossRef] [PubMed]
  33. Gianopulos, K.A.; Makio, A.O.; Pritchard, S.M.; Cunha, C.W.; Hull, M.A.; Nicola, A.V. Herpes Simplex Virus 1 Glycoprotein B from a Hyperfusogenic Virus Mediates Enhanced Cell-Cell Fusion. Viruses 2024, 16, 251. [Google Scholar] [CrossRef] [PubMed]
  34. Dean, H.J.; Terhune, S.S.; Shieh, M.T.; Susmarski, N.; Spear, P.G. Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell-type-dependent alterations in infectivity. Virology 1994, 199, 67–80. [Google Scholar] [CrossRef]
  35. Lingen, M.; Seck, T.; Weise, K.; Falke, D. Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1. J. Gen. Virol. 1995, 76, 1843–1849. [Google Scholar] [CrossRef]
  36. Saharkhiz-Langroodi, A.; Holland, T.C. Identification of the fusion-from-without determinants of herpes simplex virus type 1 glycoprotein B. Virology 1997, 227, 153–159. [Google Scholar] [CrossRef]
  37. Sayers, C.L.; Elliott, G. Herpes Simplex Virus 1 Enters Human Keratinocytes by a Nectin-1-Dependent, Rapid Plasma Membrane Fusion Pathway That Functions at Low Temperature. J. Virol. 2016, 90, 10379–10389. [Google Scholar] [CrossRef]
  38. Warner, M.S.; Geraghty, R.J.; Martinez, W.M.; Montgomery, R.I.; Whitbeck, J.C.; Xu, R.; Eisenberg, R.J.; Cohen, G.H.; Spear, P.G. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 1998, 246, 179–189. [Google Scholar] [CrossRef]
  39. Geraghty, R.J.; Krummenacher, C.; Cohen, G.H.; Eisenberg, R.J.; Spear, P.G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998, 280, 1618–1620. [Google Scholar] [CrossRef]
  40. Komala Sari, T.; Gianopulos, K.A.; Weed, D.J.; Schneider, S.M.; Pritchard, S.M.; Nicola, A.V. Herpes Simplex Virus Glycoprotein C Regulates Low-pH Entry. mSphere 2020, 5, e00826-19. [Google Scholar] [CrossRef]
  41. Montgomery, R.I.; Warner, M.S.; Lum, B.J.; Spear, P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996, 87, 427–436. [Google Scholar] [CrossRef]
  42. Huber, M.T.; Wisner, T.W.; Hegde, N.R.; Goldsmith, K.A.; Rauch, D.A.; Roller, R.J.; Krummenacher, C.; Eisenberg, R.J.; Cohen, G.H.; Johnson, D.C. Herpes simplex virus with highly reduced gD levels can efficiently enter and spread between human keratinocytes. J. Virol. 2001, 75, 10309–10318. [Google Scholar] [CrossRef] [PubMed]
  43. Lingen, M.; Seck, T.; Dehoust, U.; Weise, K.; Falke, D. Amino acid substitutions in glycoprotein D mediate the ability of fusion from without-positive herpes simplex virus type 1 strains to penetrate at 4 degrees and in the presence of soluble glycoprotein D. Intervirology 1995, 38, 283–289. [Google Scholar] [CrossRef] [PubMed]
  44. Wang, G.; Hernandez, R.; Weninger, K.; Brown, D.T. Infection of cells by Sindbis virus at low temperature. Virology 2007, 362, 461–467. [Google Scholar] [CrossRef]
  45. Frey, S.; Marsh, M.; Günther, S.; Pelchen-Matthews, A.; Stephens, P.; Ortlepp, S.; Stegmann, T. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J. Virol. 1995, 69, 1462–1472. [Google Scholar] [CrossRef]
  46. Kitai, Y.; Watanabe, O.; Ohmiya, S.; Kisu, T.; Ota, R.; Kawakami, K.; Katoh, H.; Fukuzawa, K.; Takeda, M.; Nishimura, H. Detailed analysis of low temperature inactivation of respiratory syncytial virus. Sci. Rep. 2024, 14, 11823. [Google Scholar] [CrossRef]
  47. Takai, Y.; Irie, K.; Shimizu, K.; Sakisaka, T.; Ikeda, W. Nectins and nectin-like molecules: Roles in cell adhesion, migration, and polarization. Cancer Sci. 2003, 94, 655–667. [Google Scholar] [CrossRef]
  48. Atanasiu, D.; Saw, W.T.; Cohen, G.H.; Eisenberg, R.J. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J. Virol. 2010, 84, 12292–12299. [Google Scholar] [CrossRef]
  49. Krummenacher, C.; Baribaud, F.; Ponce de Leon, M.; Baribaud, I.; Whitbeck, J.C.; Xu, R.; Cohen, G.H.; Eisenberg, R.J. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. Virology 2004, 322, 286–299. [Google Scholar] [CrossRef] [PubMed]
  50. Lopez, M.; Cocchi, F.; Menotti, L.; Avitabile, E.; Dubreuil, P.; Campadelli-Fiume, G. Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J. Virol. 2000, 74, 1267–1274. [Google Scholar] [CrossRef]
  51. Yoon, M.; Spear, P.G. Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage. Proc. Natl. Acad. Sci. USA 2004, 101, 17252–17257. [Google Scholar] [CrossRef]
  52. Connolly, S.A.; Landsburg, D.J.; Carfi, A.; Wiley, D.C.; Cohen, G.H.; Eisenberg, R.J. Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J. Virol. 2003, 77, 8127–8140. [Google Scholar] [CrossRef]
  53. Nicola, A.V.; Peng, C.; Lou, H.; Cohen, G.H.; Eisenberg, R.J. Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection. J. Virol. 1997, 71, 2940–2946. [Google Scholar] [CrossRef]
  54. Bzik, D.J.; Fox, B.A.; DeLuca, N.A.; Person, S. Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology 1984, 133, 301–314. [Google Scholar] [CrossRef]
  55. Bzik, D.J.; Fox, B.A.; DeLuca, N.A.; Person, S. Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: Mutations affecting rate of virus entry and cell fusion. Virology 1984, 137, 185–190. [Google Scholar] [CrossRef]
  56. Falke, D.; Knoblich, A.; Müller, S. Fusion from without induced by herpes simplex virus type 1. Intervirology 1985, 24, 211–219. [Google Scholar] [CrossRef] [PubMed]
  57. Dollery, S.J.; Delboy, M.G.; Nicola, A.V. Low pH-induced conformational change in herpes simplex virus glycoprotein B. J. Virol. 2010, 84, 3759–3766. [Google Scholar] [CrossRef] [PubMed]
  58. Dollery, S.J.; Wright, C.C.; Johnson, D.C.; Nicola, A.V. Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity. J. Virol. 2011, 85, 9964–9973. [Google Scholar] [CrossRef] [PubMed]
  59. Siekavizza-Robles, C.R.; Dollery, S.J.; Nicola, A.V. Reversible conformational change in herpes simplex virus glycoprotein B with fusion-from-without activity is triggered by mildly acidic pH. Virol. J. 2010, 7, 352. [Google Scholar] [CrossRef]
  60. Satoh, T.; Arii, J.; Suenaga, T.; Wang, J.; Kogure, A.; Uehori, J.; Arase, N.; Shiratori, I.; Tanaka, S.; Kawaguchi, Y.; et al. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 2008, 132, 935–944. [Google Scholar] [CrossRef]
  61. Arii, J.; Goto, H.; Suenaga, T.; Oyama, M.; Kozuka-Hata, H.; Imai, T.; Minowa, A.; Akashi, H.; Arase, H.; Kawaoka, Y.; et al. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 2010, 467, 859–862. [Google Scholar] [CrossRef]
  62. White, J.; Kartenbeck, J.; Helenius, A. Membrane fusion activity of influenza virus. EMBO J. 1982, 1, 217–222. [Google Scholar] [CrossRef] [PubMed]
  63. White, J.; Kartenbeck, J.; Helenius, A. Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. J. Cell Biol. 1980, 87, 264–272. [Google Scholar] [CrossRef] [PubMed]
  64. Kotsakis, A.; Pomeranz, L.E.; Blouin, A.; Blaho, J.A. Microtubule reorganization during herpes simplex virus type 1 infection facilitates the nuclear localization of VP22, a major virion tegument protein. J. Virol. 2001, 75, 8697–8711. [Google Scholar] [CrossRef] [PubMed]
  65. Pomeranz, L.E.; Blaho, J.A. Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection. J. Virol. 1999, 73, 6769–6781. [Google Scholar] [CrossRef]
  66. Rubin, R.W.; Weiss, G.D. Direct biochemical measurements of microtubule assembly and disassembly in Chinese hamster ovary cells. The effect of intercellular contact, cold, D2O, and N6,O2′-dibutyryl cyclic adenosine monophosphate. J. Cell Biol. 1975, 64, 42–53. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Article metric data becomes available approximately 24 hours after publication online.
Download PDF
Seroprevalence of Hepatitis A Virus (HAV) and Hepatitis E Virus (HEV) Among Blood Donor Candidates in Salvador, Bahia, Brazil
Previous
First Record of Isolation and Molecular Characterization of Aguas Brancas virus, a New Insect-Specific Virus Found in Brazil
Next